Satoshi Terae
Overview
Explore the profile of Satoshi Terae including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
98
Citations
936
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kato D, Terae S
No Shinkei Geka
. 2021 Mar;
49(2):356-361.
PMID: 33762457
A woman in her 60s was admitted to our hospital because of sudden-onset right hemiparesis, paresthesia, and neck pain. At first, a head CT scan was performed to rule out...
2.
Yaguchi H, Mito Y, Terae S, Tajima Y
Intern Med
. 2021 Feb;
60(15):2507-2508.
PMID: 33612685
No abstract available.
3.
Maruo Y, Egawa K, Tonoki H, Terae S, Ueda Y, Shiraishi H
Pediatr Neurol
. 2021 Jan;
116:55-56.
PMID: 33485032
No abstract available.
4.
Baba S, Miyoshi A, Obara S, Usubuchi H, Terae S, Sunahara M, et al.
Endocrinol Diabetes Metab Case Rep
. 2021 Jan;
2020.
PMID: 33434178
Summary: A 31-year-old man with Williams syndrome (WS) was referred to our hospital because of a 9-year history of hypertension, hypokalemia, and high plasma aldosterone concentration to renin activity ratio....
5.
Otsuka K, Egawa K, Fujima N, Kudo K, Terae S, Nakajima M, et al.
Epilepsy Behav
. 2020 Dec;
114(Pt A):107516.
PMID: 33323336
Objective: This study examined whether the application of magnetoencephalography (MEG) to interpret magnetic resonance imaging (MRI) findings can aid the diagnosis of intractable epilepsy caused by organic brain lesions. Methods:...
6.
Wada N, Miyoshi A, Usubuchi H, Terae S, Shibayama Y, Takahashi B, et al.
Endocr J
. 2020 Aug;
68(1):45-51.
PMID: 32848105
Captopril challenge test (CCT) is a simple and safe confirmatory test for primary aldosteronism (PA). We investigated the effectiveness of the indices after captopril administration for prediction of unilateral hyperaldosteronism...
7.
Mito Y, Yabe I, Yaguchi H, Sato C, Takei T, Terae S, et al.
Clin Neurol Neurosurg
. 2020 Jun;
196:105960.
PMID: 32593043
Objectives: The aim of the present study was to determine the relations of clinical symptoms with nigrostriatal neuron loss in drug-naïve patients with Parkinson's disease (PD). We examined the severity...
8.
Mito Y, Yabe I, Yaguchi H, Sato C, Takei T, Terae S, et al.
Clin Neurol Neurosurg
. 2020 Jun;
195:105951.
PMID: 32492588
Objectives: The aim of the present study was to determine the relationships of drooling with motor symptoms and nigrostriatal neuron loss in drug-naïve patients with Parkinson's disease (PD). We therefore...
9.
Anada M, Tohyama M, Oda Y, Kamoshima Y, Amino I, Nakano F, et al.
Intern Med
. 2020 May;
59(16):2053-2059.
PMID: 32448834
A 61-year-old woman was diagnosed with rheumatoid arthritis 12 years ago and received multiple treatment regimens before achieving symptomatic stability with methotrexate plus tocilizumab, a humanized monoclonal antibody against the...
10.
Shibayama Y, Wada N, Baba S, Obara S, Sakai H, Usubuchi H, et al.
Endocr J
. 2020 Mar;
67(6):623-629.
PMID: 32213734
Patients with primary aldosteronism (PA) are complicated by metabolic syndrome more frequently than those without PA. Hyperaldosteronism has been reported to be associated with a higher prevalence of non-alcoholic fatty...